Redirecting to deep profile of Amit Verma at Molq Health Services...
Click here to continueBelow are the verified contact details to help you connect directly:
Email: ami*****@mol******.com
Mobile: 87197*****
Estimated Net Worth: ₹0 – ₹500+ Cr (approx. $0 – $60M)
- Amit Verma is the Founder and CEO of MolQ Health Services, establishing the organization in May 2012 to provide innovative healthcare solutions.
- Under Amit Verma's leadership, MolQ Health Services has focused on personalized therapy, significantly impacting patient treatment plans and outcomes.
- Amit Verma is also the Founder and CEO of Dr. AV Institute of Personalized Therapy & Research Institute since June 2021, further advancing the field of individualized medicine.
- Prior to founding MolQ Health Services, Amit Verma served as a Senior Consultant in Molecular Oncology and Cancer Genetics at Max Cancer Centre since December 2012, demonstrating expertise in cancer treatment.
- From 2010 to 2012, Amit Verma held the position of Head and Senior Consultant in Molecular Oncology at International Oncology Fortis Hospital, spearheading advancements in oncological practices.
- Amit Verma was a Senior Consultant at HealthCare Global Oncology Hospital, where contributions included research and development initiatives in cancer treatment methods until June 2012.
- Experience also includes serving as a Physician in the Department of Internal Medicine at The University of Texas Health Science Center at Houston from July 2008 to June 2009, showcasing strong foundational medical expertise.
- Amit Verma's earlier roles include a Fellowship at MD Anderson Cancer Center and various positions at Sir Ganga Ram Hospital and AIIMS, building a robust career in oncology and internal medicine.
- Throughout the career, challenges were met with a focus on enhancing cancer care through research and practice, pushing the boundaries of molecular oncology.
- The journey reflects a commitment to healthcare innovation, demonstrating a continuous effort to improve patient outcomes in oncology and personalized therapy.